Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Effectiveness of brief interventions as part of the screening, brief intervention and referral to treatment (SBIRT) model for reducing the non-medical use of psychoactive substances: a systematic review protocol
2012
Long‐term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11‐year findings from the Australian Treatment Outcome Study
2015
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018 Standout
Five-factor model personality traits in opioid dependence
2007
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility
2002 Standout
Opioid Tolerance and Hyperalgesia in Chronic Pain Patients After One Month of Oral Morphine Therapy: A Preliminary Prospective Study
2006
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
2016 Standout
Efficacy of Opioids for Chronic Pain
2008
Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998–2008
2010
Opioid use behaviors, mental health and pain—Development of a typology of chronic pain patients
2009
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction
2006
Mass spectrometric analysis of illicit drugs in wastewater and surface water
2008
Sexual behaviour in context: a global perspective
2006 Standout
Adverse Health Effects of Marijuana Use
2014 Standout
Burden of liver diseases in the world
2018 Standout
Neurexins Physically and Functionally Interact with GABAA Receptors
2010 StandoutNobel
A comparison of methadone, buprenorphine and alpha2 adrenergic agonists for opioid detoxification: A mixed treatment comparison meta-analysis
2010
Vaccines Against Drug Abuse
2011
Presynaptic Neurexin-3 Alternative Splicing trans-Synaptically Controls Postsynaptic AMPA Receptor Trafficking
2013 StandoutNobel
Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study
2009
Systematic review of prospective studies investigating “remission” from amphetamine, cannabis, cocaine or opioid dependence
2010
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review
2011
Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study
2008
Methadone versus buprenorphine in pregnant addicts: a double‐blind, double‐dummy comparison study
2006
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
2008
Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment
2009
Stroke and methamphetamine use in young adults: a review
2017
What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews
2011
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification
2008
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers
2013
Genomewide suggestive linkage of opioid dependence to chromosome 14q
2007
Acceptance and Commitment Therapy: Model, processes and outcomes
2005 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Linking “big” personality traits to anxiety, depressive, and substance use disorders: A meta-analysis.
2010 Standout
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Oral naltrexone maintenance treatment for opioid dependence
2011
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
2013 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Injection methamphetamine use is associated with an increased risk of attempted suicide: A prospective cohort study
2011
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
2012 Standout
Tapering Long-term Opioid Therapy in Chronic Noncancer Pain
2015
Office of National Drug Control Policy
2010 Standout
Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study
2003
A Single-Question Screening Test for Drug Use in Primary Care
2010
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage
2010
Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth
2012
Implementing Buprenorphine Treatment in Community Settings in Australia: Experiences from the Buprenorphine Implementation Trial
2004
HCV epidemiology in high-risk groups and the risk of reinfection
2016
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
2010
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Slow‐release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence
2004
What Is Killing People with Hepatitis C Virus Infection?
2011
Candidate gene networks and blood biomarkers of methamphetamine-associated psychosis: an integrative RNA-sequencing report
2016
Neuroligins and neurexins link synaptic function to cognitive disease
2008 StandoutNatureNobel
Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial
2008
Neuropsychological predictors of clinical outcome in opiate addiction
2007
New York inmates' HIV risk behaviors: the implications for prevention policy and programs.
1996
Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database
2010
Effects of mindfulness on psychological health: A review of empirical studies
2011 Standout
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
2017 Standout
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
The Long-Term Health Consequences of Child Physical Abuse, Emotional Abuse, and Neglect: A Systematic Review and Meta-Analysis
2012 Standout
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013
2016
Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 months later
2008
Methadone inhibits CYP2D6 and UGT2B7/2B4in vivo: a study using codeine in methadone‐ and buprenorphine‐maintained subjects
2011
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Buprenorphine Implants for Treatment of Opioid Dependence
2010
A Stepped Care Strategy Using Buprenorphine and Methadone Versus Conventional Methadone Maintenance in Heroin Dependence: A Randomized Controlled Trial
2007
Release from Prison — A High Risk of Death for Former Inmates
2007 Standout
Recent contact with health and social services by drug misusers in Glasgow who died of a fatal overdose in 1999
2002
Computational design of ligand-binding proteins with high affinity and selectivity
2013 StandoutNatureNobel
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation
2007
Child maltreatment as a risk factor for opioid dependence: Comparison of family characteristics and type and severity of child maltreatment with a matched control group
2009
The first application of wastewater-based drug epidemiology in five South Korean cities
2015
Cancer Chemotherapy and Cardiac Arrhythmias: A Review
2015
Retention in methadone and buprenorphine treatment among African Americans
2013
The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making
2010
Chiral Brønsted acid catalyzed Friedel–Crafts alkylation reactions
2009 Standout
Treatment for Hepatitis C Virus Infection among Current Injection Drug Users in Australia
2005
Opioid Tolerance and Hyperalgesia
2007
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
A Preliminary trial of twelve-step facilitation and acceptance and commitment therapy with polysubstance-abusing methadone-maintained opiate addicts
2004
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
2009
Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006–10
2015
The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study
2014
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
2014 Standout
β-Phenylethylamines and the isoquinoline alkaloids
2004
Opioid-induced Hyperalgesia
2006
Primary Care–Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence
2014
Opioid maintenance: a comparative review of pharmacological strategies
2006
A Preliminary Study Comparing Methadone and Buprenorphine in Patients with Chronic Pain and Coexistent Opioid Addiction
2013
Methadone maintenance at different dosages for opioid dependence
2003
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
2009 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
AIDS in Mexico: lessons learned and implications for developing countries
2002
Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study
2015
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF
2018
A pilot study for a randomized controlled and patient preference trial of buprenorphine versus methadone maintenance treatment in the management of opiate dependent patients
2008
Syphilis and HIV Infection among Prisoners in Maputo, Mozambique
1995
Ecological Momentary Assessment
2007 Standout
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
2016
Male circumcision for prevention of heterosexual acquisition of HIV in men
2009 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Opioid Prescriptions for Chronic Pain and Overdose
2010 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
2015 Standout
Planning and Designing the Improving Addiction Care Team (IMPACT) for Hospitalized Adults with Substance Use Disorder
2017
Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification
2011
Medication-Assisted Treatment With Methadone: Assessing the Evidence
2013
Cross-Dehydrogenative Coupling (CDC): Exploring C−C Bond Formations beyond Functional Group Transformations
2008 Standout
Pharmacologic treatments for opioid dependence: detoxification and maintenance options.
2007
Nitrated Confined Imidodiphosphates Enable a Catalytic Asymmetric Oxa-Pictet–Spengler Reaction
2016 StandoutNobel
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
2017
Pharmacologic treatments for opioid dependence: detoxification and maintenance options
2007
Relapse and Relapse Prevention
2007
Prescription Opioid Duration of Action and the Risk of Unintentional Overdose Among Patients Receiving Opioid Therapy
2015
LAAM maintenance vs methadone maintenance for heroin dependence
2002
Works of Robert Ali being referenced
Oral substitution treatment of injecting opioid users for prevention of HIV infection
2011
Correlates of retention on the South Australian Methadone Program 1981-91
1998
Flexible dosing of Tincture of Opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics
2008
Therapeutic use of cannabis: clarifying the debate
1998
Buprenorphine for the management of opioid withdrawal
2009
Experience of non‐fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions
1998
Introducing a new entity: chemotherapy-induced arrhythmia
2009
Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)
2005
Hyperalgesic responses in methadone maintenance patients
2001
Buprenorphine versus methadone maintenance therapy: a randomized double‐blind trial with 405 opioid‐dependent patients
2003
Relationship between LAAM–methadone preference and treatment outcomes
2002
Psychotic symptoms in methamphetamine psychotic in-patients
2003
Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS
2008
The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS)
2005
BRIEF REPORT: Methadone Treatment of Injecting Opioid Users for Prevention of HIV Infection
2005
One year outcomes for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS)
2005
Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis
2011
The rise of methamphetamine in Southeast and East Asia
2008
Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal
2002
A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months
2002
Exposure to opioid maintenance treatment reduces long‐term mortality
2008
Systematic review processes and the management of opioid withdrawal
2000
Substitution treatment of injecting opioid users for prevention of HIV infection
2004
Abstinence-orientated buprenorphine replacement therapy for young adults in out-patient counselling
2006
Opioid antagonists with minimal sedation for opioid withdrawal
2002
A review of biological indicators of illicit drug use, practical considerations and clinical usefulness
1999
The place of detoxification in treatment of opioid dependence
2006
Heroin users in Australia: population trends
2004
Validation of the alcohol, smoking and substance involvement screening test (ASSIST)
2008
A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: Do stable patients receive more unsupervised doses?
2014
HIV prevalence and risk behaviours for HIV transmission in South Australian prisons
1991
The effectiveness of a brief intervention for illicit drugs linked to the alcohol, smoking and substance involvement screening test (ASSIST) in primary health care settings: a technical report of phase iii findings of the WHO ASSIST randomized controlled trial.
2008
Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) 2000
2000
Short-term Outcomes for the Treatment of Heroin Dependence
2006
Alpha2-adrenergic agonists for the management of opioid withdrawal
2016
Comment on: Doverty et al., Hyperalgesic responses in methadone maintenance patients (Pain 2001;90;91–6)
2002
Bloody needles
1991
A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health‐care settings in four countries
2011
Evaluating the impact of community‐based treatment options on methamphetamine use: findings from the M ethamphetamine T reatment E valuation S tudy (MATES )
2012
HIV prevalence and risk behaviour in needle exchange attenders: a national study
1997
Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal
2010
Methadone at tapered doses for the management of opioid withdrawal
2013
Opioid antagonists with minimal sedation for opioid withdrawal
2017